Olema Pharmaceuticals(OLMA) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update SAN FRANCISCO, May 8, 2024 – Olema Pharmaceuticals, Inc. ("Olema", "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women's cancers, today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update. "Our mission at Olema is uniquely focused on advancin ...